Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Money Cat Consulting is a global strategic advisory and marketing communications firm specializing in the biotechnology and pharmaceutical sectors. Founded and led by CEO Thomas Su, the company provides a range of services including international internet marketing, investor relations, and corporate advisory to help life science companies expand their presence, particularly in Asian markets. The firm is recognized for producing detailed industry research reports and whitepapers that analyze capital raising trends and market dynamics within the biotech industry. By bridging the gap between healthcare innovation and global investment, Money Cat Consulting supports the growth and visibility of emerging biotech ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Money Cat Consulting.